Meta-omics characteristics of intestinal microbiota associated to HBeAg seroconversion induced by oral antiviral therapy

Tenofovir and entecavir are currently designated as the preferred oral antiviral drugs for chronic hepatitis B. However, only less than 40% of patients can achieve HBeAg seroconversion. We aim at investigating the role of intestinal microbiome in HBeAg seroconversion induced by oral antiviral therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yu-Li, Qin, Lei, Wei, Wen-Jun, Cai, Hong, Yu, Xiao-Fang, Zhang, Wei, Wu, Xiao-Lu, Liu, Xiao-Bin, Chen, Wei-Ming, You, Pan, Hong, Mei-Zhu, Liu, Yaming, Dong, Xuan, Shia, Ben-Chang, Niu, Jian-Jun, Pan, Jin-Shui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864979/
https://www.ncbi.nlm.nih.gov/pubmed/33547384
http://dx.doi.org/10.1038/s41598-021-82939-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864979/
https://www.ncbi.nlm.nih.gov/pubmed/33547384
http://dx.doi.org/10.1038/s41598-021-82939-1

Ejemplares similares